Bank of New York Mellon
AUGX

Bank of New York Mellon’s Augmedix, Inc. Common Stock AUGX Stock Holding History

Bank of New York Mellon’s Portfolio AUGX Stock Details AUGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-17,289
Closed -$101K – 4341
2023
Q4 		$101K Hold
17,289
– – ﹤0.01% 4079
2023
Q3 		$89K Sell
17,289
-78
-0.4% -$366 ﹤0.01% 4097
2023
Q2 		$83.5K Buy
+17,367
New +$60.1K ﹤0.01% 4107

Other funds holding AUGX

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
SM
Samjo Management New York $231M AUM 13.04% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Bank of New York Mellon's AUGX Position: Q1 2024 in Review

Bank of New York Mellon sold out of Augmedix, Inc. Common Stock (AUGX) in Q1 2024, closing a stake of 17,289 shares — an estimated $101K sold.

Bank of New York Mellon first reported a position in AUGX in Q2 2023 and held it in 3 quarters. The position peaked at $101K in Q4 2023. 84 funds tracked by Wall St. Rank hold AUGX as of Q1 2024.

  • Bank of New York Mellon reported no remaining Augmedix, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Bank of New York Mellon sold 17,289 Augmedix, Inc. Common Stock shares in Q1 2024, an estimated $101K.
  • Bank of New York Mellon first reported a position in Augmedix, Inc. Common Stock in Q2 2023 and held it in 3 quarters.
  • Bank of New York Mellon's Augmedix, Inc. Common Stock position peaked at $101K in Q4 2023.
  • 84 funds tracked by Wall St. Rank held Augmedix, Inc. Common Stock as of Q1 2024.

Based on Bank of New York Mellon's 13F filing for Q1 2024, filed 25 Apr 2024.